Login / Signup

T-cell tolerant fraction as a predictor of immune-related adverse events.

Jared OstmeyerJason Y ParkMitchell S von ItzsteinDavid HsiehchenFarjana FattahMary GwinRodrigo CatalanShaheen KhanPrithvi RajEdward K WakelandYang XieDavid E Gerber
Published in: Journal for immunotherapy of cancer (2023)
Among patients receiving ICI, the baseline T-cell tolerant fraction may serve as a predictor of clinically significant irAEs.
Keyphrases